Baird Initiates Coverage On ESAB with Outperform Rating, Announces Price Target of $53
Baird analyst Mircea Dobre initiates coverage on ESAB (NYSE:ESAB) with a Outperform rating and announces Price Target of $53.
ESAB Q2 EPS $1.14 Beats $1.01 Estimate, Sales $661.00M Beat $635.95M Estimate
ESAB (NYSE:ESAB) reported quarterly earnings of $1.14 per share which beat the analyst consensus estimate of $1.01 by 12.87 percent. The company reported quarterly sales of $661.00 million which beat the analyst
Earnings Scheduled For August 9, 2022
Companies Reporting Before The Bell
• Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.
Stifel Initiates Coverage On ESAB with Buy Rating, Announces Price Target of $56
Stifel analyst Nathan Jones initiates coverage on ESAB (NYSE:ESAB) with a Buy rating and announces Price Target of $56.
ESAB Q1 Adj. EPS $1.17 Up From $1.12 YoY, Sales $647.91M Up From $568.13M YoY
ESAB (NYSE:ESAB) reported quarterly earnings of $1.17 per share. This is a 4.46 percent increase over earnings of $1.12 per share from the same period last year. The company reported $647.91 million in sales this
11 Industrials Stocks Moving In Wednesday’s Intraday Session
Gainers
China Index Holdings (NASDAQ:CIH) stock moved upwards by 17.0% to $1.17 during Wednesday's regular session. The market value of their outstanding shares is at $105.7 million.